FrancophonIA/ELRC3.0 huggingface dataset:
English: At the end of the infusion, patients should be switched to maintenance treatment by mouth with clopidogrel, ticagrelor or prasugrel.
Croatian: Po završetku infuzije, bolesnika treba prebaciti na terapiju održavanja peroralnim klopidogrelom, tikagrelorom ili prasugrelom.
English: Kengrexal was compared with clopidogrel taken by mouth in one main study involving over 11,000 adults with coronary artery disease who were undergoing PCI.
Croatian: Kengrexal je uspoređen s klopidogrelom koji se uzima peroralno u jednom glavnom ispitivanju koje je obuhvatilo više od 11.000 odraslih osoba s koronarnom arterijskom bolešću, koji su podvrgnuti PCI-u.
English: The active substance in Kengrexal, cangrelor, is an antiplatelet medicine.
Croatian: Djelatna tvar u lijeku Kengrexal, kangrelor, je antitrombocitni lijek.
English: Other information about Kengrexal
Croatian: Ostale informacije o lijeku Kengrexal
English: A risk management plan has been developed to ensure that Kengrexal is used as safely as possible.
Croatian: Pripremljen je plan upravljanja rizikom kako bi se osigurala što sigurnija primjena lijeka Kengrexal.
English: What are the risks associated with Kengrexal?
Croatian: Koji su rizici povezani s lijekom Kengrexal?
English: Kengrexal is a blood-thinning medicine used to reduce the occurrence of problems caused by blood clots, such as heart attack.
Croatian: Kengrexal je lijek za razrjeđivanje krvi koji se koristi za ublažavanje problema uzrokovanih krvnim ugrušcima, poput zastoja srca.
English: Based on this plan, safety information has been included in the summary of product characteristics and the package leaflet for Kengrexal, including the appropriate precautions to be followed by healthcare professionals and patients.
Croatian: Na temelju tog plana u sažetku opisa svojstava lijeka kao i u uputi o lijeku za Kengrexal nalaze se sigurnosne informacije, uključujući odgovarajuće mjere opreza kojih se zdravstveni djelatnici i bolesnici trebaju pridržavati.
English: The most serious side effects with Kengrexal include severe and life-threatening bleeding and hypersensitivity (allergic) reactions.
Croatian: Najozbiljnije nuspojave povezane s lijekom Kengrexal uključuju ozbiljno i po život opasno krvarenje i preosjetljive (alergijske) reakcije.
English: This stops the platelets becoming ‘sticky', reducing the risk of a blood clot forming.
Croatian: Time se sprječava da trombociti postanu ljepljivi, što smanjuje rizik od formiranja krvnih ugrušaka.
English: It is not intended to provide practical advice on how to use Kengrexal.
Croatian: Svrha sažetka nije davati praktične savjete o primjeni lijeka Kengrexal.
English: Kengrexal was also investigated in one study in which it was given before surgery to patients who had been previously treated with blood-thinning medicines taken by mouth.
Croatian: Kengrexal je također ispitan u jednom ispitivanju u kojem je primijenjen prije kirurškog zahvata u bolesnika koji su prethodno liječeni lijekovima za razrjeđivanje krvi koji se uzimaju peroralno.
English: Kengrexal cangrelor
Croatian: Kengrexal kangrelor
English: The most common side effects with Kengrexal (which may affect up to 1 in 10 people) include mild and moderate bleeding and dyspnoea (difficulty breathing).
Croatian: Najčešće nuspojave lijeka Kengrexal? (mogu se javiti u više od 1 na 10 osoba) uključuju blago i umjereno krvarenje i dispneju (otežano disanje).
English: The full EPAR and risk management plan summary for Kengrexal can be found on the Agency's website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
Croatian: Cjeloviti EPAR kao i sažetak plana upravljanja rizikom za lijek Kengrexal nalaze se na internetskim stranicama Agencije: ema.europa.eu/Find medicine/Human medicines/European public assessment reports Više informacija o terapiji lijekom Kengrexal pročitajte u uputi o lijeku (također dio EPAR-a) ili se obratite svom liječniku ili ljekarniku.
English: Kengrexal is available as a powder to be made up into a solution for injection and infusion (drip) into a vein.
Croatian: Kengrexal je dostupan kao koncentrat za otopinu za injekciju i infuziju (drip) u venu.
English: For practical information about using Kengrexal, patients should read the package leaflet or contact their doctor or pharmacist.
Croatian: Praktične informacije o korištenju lijeka Kengrexal bolesnici trebaju pročitati u uputi o lijeku, odnosno obratiti se svom liječniku ili ljekarniku.
English: Cangrelor stops the platelets sticking together by blocking a substance called ADP from attaching to their surface.
Croatian: Kangrelor sprječava trombocite da se slijepe tako što inhibira vezivanje tvari naziva ADP na površinu.
English: What benefits of Kengrexal have been shown in studies?
Croatian: Koje su koristi lijeka Kengrexal utvrđene u ispitivanjima?
English: Kengrexal should be given by a doctor who is experienced in the treatment of coronary disease or in PCI procedures.
Croatian: Kengrexal mora primjenjivati liječnik s iskustvom u akutnoj koronarnoj njezi ili u postupcima PCI-a.
English: Kengrexal contains the active substance cangrelor.
Croatian: Kengrexal sadrži djelatnu tvar kangrelor.
English: How is Kengrexal used?
Croatian: Kako se Kengrexal koristi?
English: How does Kengrexal work?
Croatian: Kako djeluje Kengrexal?
English: For the full list of all side effects reported with Kengrexal, see the package leaflet.
Croatian: Potpuni popis nuspojava zabilježenih pri primjeni lijeka Kengrexal potražite u uputi o lijeku.
English: A decision must be made whether to discontinue breast-feeding or to discontinue/abstain from Azomyr therapy taking into account the benefit of breast feeding for the child and the benefit of therapy for the woman.
Croatian: Potrebno je odlučiti da li prekinuti dojenje ili prekinuti liječenje/suzdržati se od liječenja lijekom Azomyr uzimajući u obzir korist dojenja za dijete i korist liječenja za ženu.
English: In the case of severe renal insufficiency, Azomyr should be used with caution (see section 5.2).
Croatian: U slučaju teške insuficijencije bubrega, Azomyr treba oprezno primjenjivati (vidjeti dio 5.2).
English: Treatment with Azomyr also significantly reduced interference with sleep and daytime function, as measured by a four-point scale used to assess these variables.
Croatian: Liječenje lijekom Azomyr također je značajno smanjilo utjecaj na spavanje i dnevne aktivnosti, što se mjerilo skalom od četiri stupnja za procjenu tih varijabli.
English: Talk to your doctor, pharmacist or nurse before taking Azomyr: - if you have poor kidney function.
Croatian: Obratite se svom liječniku, ljekarniku ili medicinskoj sestri prije nego uzmete Azomyr: - ako imate oslabljenu funkciju bubrega.
English: Use caution when taking Azomyr with alcohol.
Croatian: Potreban je oprez kada se Azomyr uzima s alkoholom.
English: Azomyr effectively controlled symptoms for 24 hours.
Croatian: Azomyr je učinkovito kontrolirao simptome tijekom 24 sata.
English: There are no known interactions of Azomyr with other medicines.
Croatian: Nema poznatih interakcija između lijeka Azomyr i drugih lijekova.
English: As a precautionary measure, it is preferable to avoid the use of Azomyr during pregnancy.
Croatian: Kao mjera opreza, preporučuje se izbjegavati primjenu lijeka Azomyr tijekom trudnoće.
English: Other medicines and Azomyr
Croatian: Drugi lijekovi i Azomyr
English: What Azomyr is Azomyr contains desloratadine which is an antihistamine.
Croatian: Što je Azomyr Azomyr sadrži desloratadin, koji je antihistaminik.
English: The prescriber should be aware that most cases of rhinitis below 2 years of age are of infectious origin (see section 4.4) and there are no data supporting the treatment of infectious rhinitis with Azomyr.
Croatian: Liječnik koji propisuje lijek treba znati da je većina slučajeva rinitisa u djece mlađe od dvije godine infektivnog podrijetla (vidjeti dio 4.4) te da ne postoje podaci koji podupiru liječenje infektivnog rinitisa lijekom Azomyr.
English: However, the safety of desloratadine syrup formulation, which contains the same concentration of desloratadine as Azomyr oral solution, was demonstrated in three paediatric trials.
Croatian: Međutim, sigurnost primjene desloratadina u obliku sirupa, koji sadrži istu koncentraciju desloratadina kao i Aerius oralna otopina, dokazana je u tri pedijatrijska ispitivanja.
English: During the marketing of Azomyr, cases of severe allergic reactions (difficulty in breathing, wheezing, itching, hives and swelling) have been reported very rarely.
Croatian: Nakon stavljanja u promet lijeka Azomyr, slučajevi teških alergijskih reakcija (otežano disanje, zviždanje pri disanju, svrbež, koprivnjača i oticanje) bili su prijavljeni vrlo rijetko.
English: As Azomyr oral solution contains the same concentration of desloratadine, no bioequivalence study was required and it is expected to be equivalent to the syrup and tablet.
Croatian: Budući da Azomyr oralna otopina sadrži jednaku koncentraciju desloratadina, nije bilo potrebno provesti ispitivanje bioekvivalencije sa sirupom i tabletama i očekuje se da su te formulacije ekvivalentne.
English: Azomyr tablets effectively controlled symptoms for 24 hours.
Croatian: Azomyr tablete su učinkovito kontrolirale simptome tijekom 24 sata.
English: Therefore, the efficacy of Azomyr orodispersible tablet is expected to be the same as with the Azomyr tablet formulation.
Croatian: Stoga se očekuje da će djelotvornost Azomyr raspadljivih tableta za usta biti jednaka kao kod primjene Azomyr tableta.
English: In a clinical pharmacology trial, Azomyr tablets taken concomitantly with alcohol did not potentiate the performance impairing effects of alcohol (see section 5.1).
Croatian: U kliničkom farmakološkom ispitivanju, uzimanje Azomyr tableta istodobno s alkoholom nije pojačalo štetne učinke alkohola na ponašanje (vidjeti dio 5.1).
English: Azomyr contains lactose
Croatian: Azomyr sadrži laktozu
English: Water had no effect on the bioavailability of Azomyr orodispersible tablets.
Croatian: Voda nije utjecala na bioraspoloživost Azomyr raspadljivih tableta za usta.
English: What Azomyr is and what it is used for
Croatian: Što je Azomyr i za što se koristi
English: In two placebo-controlled six week trials in patients with chronic idiopathic urticaria, Azomyr was effective in relieving pruritus and decreasing the size and number of hives by the end of the first dosing interval.
Croatian: U dva placebom kontrolirana ispitivanja u trajanju od šest tjedana u bolesnika s kroničnom idiopatskom urtikarijom, Azomyr je učinkovito ublažavao pruritus i smanjivao veličinu i broj koprivnjača do kraja prvog intervala doziranja.
English: The efficacy of Azomyr tablets has not been clearly demonstrated in trials with adolescent patients 12 through 17 years of age.
Croatian: Djelotvornost Azomyr tableta još nije jasno dokazana u ispitivanjima na adolescentnim bolesnicima u dobi od 12 do 17 godina.
English: Azomyr 2.5 mg tablets has not been evaluated in paediatric patients however in conjunction with the dose finding studies in paediatrics, the pharmacokinetics data for Azomyr orodispersible tablets supports the use of the 2.5 mg dose in paediatric patients 6 to 11 years of age.
Croatian: Azomyr 2,5 mg tablete nisu ispitivane u pedijatrijskih bolesnika; međutim, farmakokinetički podaci o Azomyr raspadljivim tabletama za usta zajedno s podacima iz pedijatrijskih ispitivanja utvrđivanja doze podupiru primjenu doze od 2,5 mg u pedijatrijskih bolesnika u dobi od 6 do 11 godina.
English: Adverse reactions seen with Azomyr
Croatian: Nuspojave opažene uz Azomyr
English: What Azomyr contains
Croatian: Što Azomyr sadrži
English: Efficacy of Azomyr oral solution has not been investigated in separate paediatric trials.
Croatian: Djelotvornost Azomyr oralne otopine nije ispitivana u posebnim pedijatrijskim kliničkim ispitivanjima.
English: In clinical studies in most children and adults, side effects with Azomyr were about the same as with a dummy solution or tablet.
Croatian: U kliničkim ispitivanjima u većine djece i odraslih su nuspojave kod primjene lijeka Azomyr bile približno iste kao kod uzimanja otopine ili tableta placeba.
English: Efficacy of Azomyr syrup has not been investigated in paediatric trials in children less than 12 years of age.
Croatian: Djelotvornost Azomyr sirupa nije ispitivana u pedijatrijskim kliničkim ispitivanjima u djece mlađe od 12 godina.
English: What Azomyr is and what it is used for What you need to know before you take Azomyr How to take Azomyr
Croatian: Što je Azomyr i za što se koristi Što morate znati prije nego počnete uzimati Azomyr Kako uzimati Azomyr
English: Azomyr with food, drink and alcohol Azomyr may be taken with or without a meal.
Croatian: Azomyr s hranom, pićem i alkoholom Azomyr se može uzeti uz ili bez obroka.
English: If you forget to take Azomyr
Croatian: Ako ste zaboravili uzeti Azomyr
English: Azomyr was effective in alleviating the burden of seasonal allergic rhinitis as shown by the total score of the rhino-conjunctivitis quality of life questionnaire.
Croatian: Azomyr je bio učinkovit u ublažavanju simptoma sezonskog alergijskog rinitisa, što se vidi iz ukupnog rezultata upitnika o kvaliteti života ispitanika s rinokonjuktivitisom.
English: Azomyr tablets contain lactose.
Croatian: Azomyr tablete sadrže laktozu.
English: Azomyr orodispersible tablet with food, drink and alcohol Azomyr orodispersible tablet does not need to be taken with water or liquid.
Croatian: Azomyr raspadljive tablete za usta s hranom, pićem i alkoholom Azomyr raspadljive tablete za usta ne trebaju se uzimati s vodom ili drugom tekućinom.
English: In clinical studies with Azomyr, the following side effects were reported as:
Croatian: U kliničkim ispitivanjima s lijekom Azomyr, sljedeće nuspojave bile su prijavljene kao:
English: Azomyr tablets were effective in alleviating the burden of seasonal allergic rhinitis as shown by the total score of the rhino-conjunctivitis quality of life questionnaire.
Croatian: Azomyr tablete su bile učinkovite u ublažavanju simptoma sezonskog alergijskog rinitisa, što se vidi iz ukupnog rezultata upitnika o kvaliteti života ispitanika s rinokonjuktivitisom.
English: Azomyr 2.5 mg orodispersible tablet is light red, speckled, and round with “K” branded on one side.
Croatian: Azomyr 2,5 mg raspadljiva tableta za usta je svijetlocrvena, točkasta i okrugla tableta, s oznakom "K" na jednoj strani.
English: Azomyr oral solution with food, drink and alcohol Azomyr may be taken with or without a meal.
Croatian: Azomyr oralna otopina s hranom, pićem i alkoholom Azomyr se može uzeti uz ili bez obroka.
English: Children 1 through 5 years of age: 2.5 ml (1.25 mg) Azomyr oral solution once a day.
Croatian: Djeca u dobi od 1 do 5 godina: 2,5 ml (1,25 mg) Azomyr oralne otopine jedanput na dan.
English: Azomyr is supplied in blisters comprised of laminate blister film with foil lidding.
Croatian: Azomyr je dostupan u blisterima, a napravljeni su od laminiranog blister filma prekrivenog folijom.
English: Do not use this medicine if you notice any change in the appearance of Azomyr orodispersible tablet.
Croatian: Ovaj lijek se ne smije upotrijebiti ako primijetite bilo kakvu promjenu izgleda Azomyr raspadljivih tableta za usta.
English: How to store Azomyr oral solution Contents of the pack and other information
Croatian: Kako čuvati Azomyr oralnu otopinu Sadržaj pakiranja i druge informacije
English: Azomyr 5 mg orodispersible tablet is light red, speckled, and round with “A” branded on one side.
Croatian: Azomyr 5 mg raspadljiva tableta za usta je svijetlocrvena, točkasta i okrugla tableta, s oznakom "A" na jednoj strani.
English: Azomyr 5 mg film-coated tablets are packed in blisters in packs of 1, 2, 3, 5, 7, 10, 14, 15, 20, 21, 30, 50 or 100 tablets.
Croatian: Azomyr 5 mg filmom obložene tablete pakirane su u blistere, u veličinama pakiranja od 1, 2, 3, 5, 7, 10, 14, 15, 20, 21, 30, 50 ili 100 tableta.
English: Azomyr oral solution contains sorbitol
Croatian: Azomyr oralna otopina sadrži sorbitol
English: Adults During the marketing of Azomyr, the following side effects were reported as:
Croatian: Odrasli Nakon stavljanja u promet lijeka Azomyr, sljedeće su nuspojave prijavljene kao:
English: What Azomyr looks like and contents of the pack
Croatian: Kako Azomyr izgleda i sadržaj pakiranja
English: How to store Azomyr orodispersible tablet Contents of the pack and other information
Croatian: Kako čuvati Azomyr raspadljive tablete za usta Sadržaj pakiranja i druge informacije
English: In single-dose crossover studies of Azomyr 5 mg orodispersible tablets with Azomyr 5 mg conventional tablets, the formulations were bioequivalent.
Croatian: U ispitivanjima naizmjenične primjene jedne doze Azomyr 5 mg raspadljivih tableta za usta i konvencionalnih Azomyr 5 mg tableta, te su formulacije bile bioekvivalentne.
English: Do not use this medicine after the expiry date which is stated on the carton and blister after EXP.
Croatian: Ovaj lijek se ne smije upotrijebiti nakon isteka roka valjanosti navedenog na kutiji i na blisteru iza oznake"EXP".
English: What Azomyr oral solution contains
Croatian: Što Azomyr oralna otopina sadrži
English: What you need to know before you take Azomyr
Croatian: Što morate znati prije nego počnete uzimati Azomyr
English: Azomyr orodispersible tablets are supplied in unit dose blisters comprised of laminate blister film with foil lidding.
Croatian: Azomyr raspadljive tablete za usta dostupne su u blisterima djeljivima na jedinične doze koji su napravljeni od laminiranog blister filma prekrivenog folijom.
English: During the marketing of Azomyr, the following side effects were reported as:
Croatian: Nakon stavljanja u promet lijeka Azomyr, sljedeće su nuspojave prijavljene kao:
English: Azomyr oral solution contains sorbitol.
Croatian: Azomyr oralna otopina sadrži sorbitol.
English: What Azomyr orodispersible tablet is and what it is used for What you need to know before you take Azomyr orodispersible tablet How to take Azomyr orodispersible tablet Possible side effects
Croatian: Što je Azomyr raspadljiva tableta za usta i za što se koristi Što morate znati prije nego počnete uzimati Azomyr raspadljive tablete za usta Kako uzimati Azomyr raspadljive tablete za usta Moguće nuspojave
English: If you take more Azomyr oral solution than you should Take Azomyr oral solution only as it is prescribed for you.
Croatian: Ako uzmete više Azomyr oralne otopine nego što ste trebali Uzimajte Azomyr oralnu otopinu samo na način kako Vam je propisano.
English: This product contains 1.4 mg of phenylalanine per 2.5 mg dose of Azomyr orodispersible tablet.
Croatian: Ovaj lijek sadrži 1,4 mg fenilalanina po dozi Azomyr raspadljive tablete za usta od 2,5 mg.
English: What Azomyr oral solution is and what it is used for
Croatian: Što je Azomyr oralna otopina i za što se koristi
English: How to take Azomyr
Croatian: Kako uzimati Azomyr
English: Children 6 to 11 years of age: the recommended dose of Azomyr is one 2.5 mg orodispersible tablet placed in mouth once a day.
Croatian: Djeca u dobi od 6 do 11 godina: preporučena doza lijeka Azomyr je jedna raspadljiva tableta za usta od 2,5 mg koja se stavlja u usta jedanput na dan.
English: How Azomyr works
Croatian: Kako djeluje Azomyr
English: This product contains 2.9 mg of phenylalanine per 5 mg dose of Azomyr orodispersible tablet.
Croatian: Ovaj lijek sadrži 2,9 mg fenilalanina po dozi Azomyr raspadljive tablete za usta od 5 mg.
English: Regarding the duration of treatment, your physician will determine the type of allergic rhinitis you are suffering from and will determine for how long you should take Azomyr.
Croatian: Vezano za trajanje liječenja, Vaš će liječnik odrediti od kojeg tipa alergijskog rinitisa bolujete te koliko dugo trebate uzimati Azomyr.
English: Adults and adolescents (12 years of age and over) The recommended dose of Azomyr is one tablet once a day.
Croatian: Odrasli i adolescenti (u dobi od 12 godina i stariji) Preporučena doza lijeka Azomyr je jedna tableta jedanput na dan.
English: Azomyr orodispersible tablet is packed in unit dose blisters in packs of 5, 6, 10, 12, 15, 18, 20, 30, 50, 60, 90 and 100 doses of orodispersible tablet.
Croatian: Azomyr raspadljive tablete za usta pakirane su u blistere djeljive na jedinične doze, u veličinama pakiranja od 5, 6, 10, 12, 15, 18, 20, 30, 50, 60, 90 i 100 raspadljivih tableta za usta.
English: Children 6 through 11 years of age: 5 ml (2.5 mg) Azomyr oral solution once a day.
Croatian: Djeca u dobi od 6 do 11 godina: 5 ml (2,5 mg) Azomyr oralne otopine jedanput na dan.
English: At the recommended dose, Azomyr 5 mg orodispersible tablet was found to be bioequivalent to the Azomyr 5 mg conventional tablet formulation of desloratadine.
Croatian: Utvrđeno je da je Azomyr 5 mg raspadljiva tableta za usta u preporučenoj dozi bioekvivalentna formulaciji desloratadina u obliku konvencionalne Azomyr 5 mg tablete.
English: What Azomyr orodispersible tablet is and what it is used for
Croatian: Što je Azomyr raspadljiva tableta za usta i za što se koristi
English: Azomyr is indicated in adults, adolescents and children over the age of 1 year for the relief of symptoms associated with: - allergic rhinitis (see section 5.1) - urticaria (see section 5.1)
Croatian: Azomyr je indiciran u odraslih, adolescenata i djece starije od 1 godine za ublažavanje simptoma povezanih s: - alergijskim rinitisom (vidjeti dio 5.1) - urtikarijom (vidjeti dio 5.1)
English: Azomyr 0.5 mg/ml oral solution desloratadine
Croatian: Azomyr 0,5 mg/ml oralna otopina desloratadin
English: When Azomyr should be used
Croatian: Kada treba uzimati Azomyr
English: What you need to know before you take Azomyr orodispersible tablet
Croatian: Što morate znati prije nego počnete uzimati Azomyr raspadljive tablete za usta
English: Azomyr tablets given at a single daily dose of 7.5 mg to adults and adolescents did not affect psychomotor performance in clinical trials.
Croatian: Azomyr tablete primijenjene u jednokratnoj dnevnoj dozi od 7,5 mg odraslima i adolescentima nisu imale učinak na psihomotorne sposobnosti u kliničkim ispitivanjima.
English: Regarding the duration of treatment, your physician will determine the type of allergic rhinitis you are suffering from and will determine for how long you should take Azomyr orodispersible tablets.
Croatian: Vezano za trajanje liječenja, Vaš će liječnik odrediti od kojeg tipa alergijskog rinitisa bolujete te koliko dugo trebate uzimati Azomyr raspadljive tablete za usta.
English: Azomyr orodispersible tablet is an antiallergy medicine that does not make you drowsy.
Croatian: Azomyr raspadljiva tableta za usta je lijek protiv alergije koji ne izaziva pospanost.
English: 6.1 List of excipients sorbitol, propylene glycol, sucralose E 955, hypromellose 2910, sodium citrate dihydrate, natural and artificial flavour (bubblegum), citric acid anhydrous, disodium edetate, purified water
Croatian: 6.1 Popis pomoćnih tvari sorbitol propilenglikol sukraloza (E955) hipromeloza 2910 natrijev citrat, dihidrat prirodna i umjetna aroma (žvakaća guma) citratna kiselina, bezvodna dinatrijev edetat voda, pročišćena
English: Azomyr 0.5 mg/ml oral solution
Croatian: Azomyr 0,5 mg/ml oralna otopina
English: Azomyr is an antiallergy medicine that does not make you drowsy.
Croatian: Azomyr je lijek protiv alergije koji ne izaziva pospanost.
English: Azomyr given at a single daily dose of 7.5 mg did not affect psychomotor performance in clinical trials.
Croatian: Azomyr primijenjen u jednokratnoj dnevnoj dozi od 7,5 mg nije imao učinak na psihomotorne sposobnosti u kliničkim ispitivanjima.
English: EU/1/00/157/059 30 ml with 1 spoon EU/1/00/157/060 50 ml with 1 spoon EU/1/00/157/061 60 ml with 1 spoon EU/1/00/157/062 100 ml with 1 spoon EU/1/00/157/063 120 ml with 1 spoon EU/1/00/157/064 150 ml with 1 spoon EU/1/00/157/067 150 ml with 1 oral syringe EU/1/00/157/065 225 ml with 1 spoon EU/1/00/157/066 300 ml with 1 spoon
Croatian: EU/1/00/157/059 30 ml s 1 žličicom EU/1/00/157/060 50 ml s 1 žličicom EU/1/00/157/061 60 ml s 1 žličicom EU/1/00/157/062 100 ml s 1 žličicom EU/1/00/157/063 120 ml s 1 žličicom EU/1/00/157/064 150 ml s 1 žličicom EU/1/00/157/067 150 ml s 1 štrcaljkom za usta EU/1/00/157/065 225 ml s 1 žličicom EU/1/00/157/066 300 ml s 1 žličicom